Prevention of psychedelic side effects associated with low dose continuous intravenous ketamine;Prévenir les hallucinations aiguës associées à la perfusion intraveineuse continue de kétamine

Therapie

Volumn 62, Issue 6, 2007, Pages 499-505

  Remerand, Francis ^a   Couvret, Claude ^a   Pourrat, Xavier ^a   Tendre, Charlotte Le ^a   Baud, Annick ^a   Fusciardi, Jacques ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Analgesia; Ketamine; Side effects

Indexed keywords

ANTIDIABETIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPIN 2 ONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DROPERIDOL; KETAMINE; KETOPROFEN; MORPHINE; NEFOPAM; PARACETAMOL; PSYCHOTROPIC AGENT;

ADD ON THERAPY; AGED; ANXIETY; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEATH; HALLUCINATION; HUMAN; HYPOTHESIS; INTRAVENOUS CATHETER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 48749126412     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:200802     Document Type: Article

References (19)

1. McCartney CJ, Sinha A, Katz J. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg 2004; 98: 1385-400
2. Himmelseher S, Durieux ME. Ketamine for perioperative pain management. Anesthesiology 2005; 102: 211-20
3. Chauvin M. La kétamine dans la douleur aiguë : de la pharmacologie à la clinique. Réanimation 2005; 14: 686-91
4. Richebe P, Rivat C, Rivalan B. Kétamine à faibles doses : antihyperalgésique, non-analgésique. Ann Fr Anesth Reanim 2005; 24 : 1349-59
5. Elia N, Tramer MR. Ketamine and postoperative pain - a quantitative systematic review of randomised trials. Pain 2005; 113: 61-70
6. Bell RF, Dahl JB, Moore RA, et al. Peri-operative ketamine for acute postoperative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand 2005; 49: 1405-28
7. Sveticic G, Eichenberger U, Curatolo M. Safety of mixture of morphine with ketamine for postoperative patient-controlled analgesia: an audit with 1026 patients. Acta Anaesthesiol Scand 2005; 49: 870-5
8. Stubhaug A, Breivik H, Eide PK, et al. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997; 41: 1124-32
9. Guillou N, Tanguy M, Seguin P, et al. The effects of small-dose ketamine on morphine consumption in surgical intensive care unit patients after major abdominal surgery. Anesth Analg 2003; 97: 843-7
10. Adam F, Chauvin M, Du Manoir B, et al. Small-dose ketamine infusion improves postoperative analgesia and rehabilitation after total knee arthroplasty. Anesth Analg 2005; 100: 475-80
11. Joly V, Richebe P, Guignard B, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005; 103: 147-55
12. Suzuki M, Haraguti S, Sugimoto K, et al. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology 2006; 105: 111-9
13. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother 2006; 60: 341-8
14. Guignard B, Coste C, Costes H, et al. Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth Analg 2002; 95: 103-8
15. Suzuki M, Tsueda K, Lansing PS, et al. Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes. Can J Anaesth 2000; 47: 866-74
16. Krystal JH, Karper LP, Bennett A, et al. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl) 1998; 135: 213-29
17. Krystal JH, D'Souza DC, Karper LP, et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl) 1999; 145: 193-204
18. Anand A, Charney DS, Oren DA, et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 2000; 57: 270-76
19. Krupitsky EM, Burakov AM, Romanova TN, et al. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. Neuropsychopharmacology 2001; 25: 936-47